HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vitro antifungal susceptibility patterns of Trichophyton benhamiae complex isolates from diverse origin.

AbstractBACKGROUND:
Species from the Trichophyton benhamiae complex are mostly zoophilic dermatophytes which cause inflammatory dermatophytosis in animals and humans worldwide.
OBJECTIVES:
This study was purposed to (a) to identify 169 reference and clinical dermatophyte strains from the T benhamiae complex species by molecular method and adhering to the newest taxonomy in the complex (b) to evaluate the in vitro antifungal susceptibility profile of these strains against eight common and new antifungal agents that may be used for the treatment of dermatophytosis.
METHODS:
All isolates, mainly originated from Europe but also from Iran, Japan and USA, were subjected to ITS-rDNA sequencing. The in vitro antifungal susceptibility profiles of eight common and new antifungal drugs against the isolates were determined by CLSI M38-A2 protocol and according to microdilution method.
RESULTS:
Based on the ITS-rDNA sequencing, T benhamiae was the dominant species (n = 102), followed by T europaeum (n = 29), T erinacei (n = 23), T japonicum (n = 10), Trichophyton sp (n = 4) and T eriotrephon (n = 1). MIC ranges across all isolates were as follows: luliconazole: 0.0002-0.002 µg/ml, terbinafine: 0.008-0.125 µg/ml, efinaconazole: 0.008-0.125 µg/ml, ciclopirox olamine: 0.03-0.5 µg/ml, itraconazole: 0.06-2 µg/ml, griseofulvin: 0.25-4 µg/ml, amorolfine hydrochloride: 0.125-4 µg/ml and tavaborole: 1-16 µg/ml.
CONCLUSION:
Luliconazole, efinaconazole and terbinafine were the most potent antifungals against T benhamiae complex isolates, regardless of the geographic locations where strains were isolated. These data might help dermatologists to develop effective therapies for successful treatment of infections due to T benhamiae complex species.
AuthorsForough Shamsizadeh, Saham Ansari, Ali Zarei Mahmoudabadi, Vít Hubka, Adéla Čmoková, Jacques Guillot, Abdollah Rafiei, Kamiar Zomorodian, Sadegh Nouripour-Sisakht, Kambiz Diba, Tooba Mohammadi, Hossein Zarrinfar, Ali Rezaei-Matehkolaei
JournalMycoses (Mycoses) Vol. 64 Issue 11 Pg. 1378-1386 (Nov 2021) ISSN: 1439-0507 [Electronic] Germany
PMID33864711 (Publication Type: Journal Article)
Copyright© 2021 Wiley-VCH GmbH.
Chemical References
  • Antifungal Agents
Topics
  • Animals
  • Antifungal Agents (pharmacology, therapeutic use)
  • Arthrodermataceae (classification, drug effects, genetics, isolation & purification)
  • Europe
  • Humans
  • Iran
  • Japan
  • Tinea (drug therapy, microbiology)
  • United States
  • Zoonoses (drug therapy, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: